So one of my clients at the moment is a big pharmaceutical company and they have one tough problem at the moment, they have very strong limitations in the Swiss market to talk about their drugs. They cannot talk to the patients, they can only talk and al...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
